Kario, Kazuomi http://orcid.org/0000-0002-8251-4480
Weber, Michael A.
Böhm, Michael
Townsend, Raymond R.
Mahfoud, Felix
Schmieder, Roland E.
Tsioufis, Konstantinos
Cohen, Sidney A.
Fahy, Martin
Kandzari, David E.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial
https://doi.org/10.1007/s00392-020-01718-6
One-Year Outcomes in “Real-World” Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Study [PE-Plus PAS])
https://doi.org/10.1016/j.amjcard.2015.11.043
Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED
https://doi.org/10.1161/hypertensionaha.123.22251
The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications
https://doi.org/10.1016/j.ahj.2015.08.021
Update on advanced interventional neuromodulatory approaches to lower blood pressure
https://doi.org/10.1136/heartjnl-2022-321499
Funding for this research was provided by:
Medtronic
Article History
Received: 13 May 2020
Accepted: 22 July 2020
First Online: 1 August 2020
Compliance with ethical standards
:
: Prof Kario has received honoraria for lectures from Medtronic, Otsuka, and Daichisankyo, ReCor, and research fund/Grant from Omron Healthcare, A&D, and Fukuda Denshi. Dr. Weber has received consulting fees from Medtronic, ReCor, Ablative Solutions, Abbvie, Johnson &Johnson, Bristol-Myers Squibb, Conjupro, Regeneron and Urovent. Prof Böhm reports support from Abbott, Astra-Zeneca, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Medtronic, Novartis, ReCor, Servier, Vifor, and by the Deutsche Forschungsgemeinschaft (DFG, TTR 219, S-01, M-03, M-05). Dr. Townsend is a consultant to Medtronic and receives royalties from UpToDate. Prof Mahfoud has received speaker honoraria from Medtronic and Recor, and is supported by Deutsche Hochdruckliga, Deutsche Gesellschaft für Kardiologie and Deutsche Forschungsgemeinschaft. Prof Schmieder has received speaker and consulting honoraria from Medtronic, ReCor, Ablative Solutions, and Rox Medical. Prof Tsioufis has received honoraria for advisory boards and lectures from Medtronic, Servier, Bayer, Menarini, Novartis, Astra-Zeneca, Boehringer In, Pfizer, Pythagoras, Sanofi, and Amgen. Dr. Cohen and Mr. Fahy are employees and shareholders of Medtronic. Dr. Kandzari has received research/Grant support from Medtronic and Ablative Solutions, and consulting honoraria from Medtronic.